Last reviewed · How we verify
SAR443122
At a glance
| Generic name | SAR443122 |
|---|---|
| Sponsor | Sanofi |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis (PHASE2)
- A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19 (PHASE1)
- Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |